Cardiac MRI Safety and Feasibility in ESRD Patients

Key Safety Considerations

Gadolinium chelate contrast agents are contraindicated in patients with advanced renal failure, including ESRD, due to the severe complication of nephrogenic systemic fibrosis, as stated by the European Heart Journal 1
The American College of Cardiology recommends assessing renal function if gadolinium contrast is planned, as GFR <30 mL/min/1.73m² significantly increases nephrogenic systemic fibrosis risk 2
The potential risks must be weighed against the benefits of contrast-enhanced rather than non-contrast CMR imaging in cases where contrast might be considered, according to the European Heart Journal 1

Gradient-echo cine imaging provides precise measurements of stroke volume, ejection fraction, and wall motion of both ventricles without requiring contrast, as recommended by the Journal of the American College of Radiology and the American College of Radiology 4
Cardiac MRI is not limited by acoustic windows or body habitus, allowing high-spatial-resolution images in essentially any plane, according to the Journal of the American College of Radiology and the American College of Radiology 4
Phase-contrast techniques quantify blood flow, regurgitant fractions, and pressure gradients across stenotic regions without contrast administration, as stated by the Journal of the American College of Radiology and the American College of Radiology 4

The KDIGO guideline recommends that people with CKD presenting with chest pain should be investigated for underlying cardiac disease according to the same local practice as people without CKD, as stated by the American Journal of Kidney Diseases 5
MRI of the heart is recommended in specific clinical contexts, though clinicians should be familiar with the limitations of non-invasive cardiac tests in adults with CKD, according to the American Journal of Kidney Diseases 5

Claustrophobia may require anxiolytic management with oral benzodiazepines (alprazolam 0.25-0.5 mg) or intranasal midazolam (1-2 mg) in approximately 5% of patients, as recommended by the European Heart Journal and the American College of Cardiology 1
Pacemakers are generally contraindicated unless MRI-conditional devices are present, as stated by the European Heart Journal 1